$242 Million is the total value of Versant Venture Management, LLC's 11 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRSP | Sell | CRISPR Therapeutics AG | $55,804,000 | -32.2% | 498,558 | -2.0% | 23.11% | -15.3% |
| PASG | Passage Bio, Inc. | $49,399,000 | -24.8% | 4,959,769 | 0.0% | 20.45% | -6.0% | |
| GRTS | Sell | Gritstone Oncology, Inc. | $43,264,000 | +6.5% | 4,005,894 | -10.0% | 17.91% | +33.1% |
| ALGS | Aligos Therapeutics, Inc. | $35,989,000 | -23.9% | 2,320,381 | 0.0% | 14.90% | -4.9% | |
| CRNX | Crinetics Pharmaceuticals, Inc. | $17,276,000 | +11.7% | 820,720 | 0.0% | 7.15% | +39.5% | |
| AKRO | Akero Therapeutics, Inc. | $13,806,000 | -9.9% | 617,727 | 0.0% | 5.72% | +12.6% | |
| ADVM | Adverum Biotechnologies, Inc. | $10,998,000 | -38.0% | 5,068,233 | 0.0% | 4.55% | -22.5% | |
| APRE | Aprea Therapeutics, Inc | $6,437,000 | +4.7% | 1,259,662 | 0.0% | 2.66% | +30.8% | |
| FLXN | Flexion Therapeutics, Inc. | $6,100,000 | -25.9% | 1,000,000 | 0.0% | 2.53% | -7.4% | |
| CBAY | CymaBay Therapeutics, Inc. | $1,985,000 | -16.3% | 543,753 | 0.0% | 0.82% | +4.6% | |
| CLVS | Clovis Oncology, Inc. | $454,000 | -23.2% | 101,855 | 0.0% | 0.19% | -4.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 35 | Q2 2023 | 10.2% |
| Clovis Oncology, Inc. | 32 | Q3 2022 | 53.2% |
| CRISPR Therapeutics AG | 23 | Q3 2023 | 77.2% |
| Ocular Therapeutix, Inc. | 22 | Q4 2020 | 18.0% |
| Gritstone Oncology, Inc. | 18 | Q3 2023 | 25.4% |
| Achaogen, Inc. | 18 | Q1 2019 | 23.5% |
| Adverum Biotechnologies, Inc. | 15 | Q3 2023 | 21.0% |
| Second Sight Medical Products, Inc. | 15 | Q3 2020 | 9.0% |
| Audentes Therapeutics, Inc. | 13 | Q3 2019 | 39.6% |
| Aligos Therapeutics, Inc. | 12 | Q3 2023 | 15.7% |
View Versant Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-11 |
| 144 | 2023-04-20 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View Versant Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.